Titan Pharmaceuticals INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Titan Pharmaceuticals director Avraham Ben-Tzvi reported the disposition of all his common stock and options following the merger with Black Titan Corporation.
Titan Pharmaceuticals, Inc. announced the filing of a Form F-4 registration statement with the SEC, containing a preliminary proxy statement/prospectus for its proposed reverse merger with TalenTec Sdn. Bhd. under the new holding company, Black Titan Corporation.
Titan Pharmaceuticals has entered into a merger agreement with KE Sdn. Bhd., a human capital management solutions provider, in a reverse merger transaction.
Form 4: Titan Pharmaceuticals Insider Choong Choon Hau Converts $500,000 Promissory Note to Common Stock
Choong Choon Hau, a director and 10% owner of Titan Pharmaceuticals, converted $500,000 of a convertible promissory note into 54,132 shares of common stock on March 18, 2024.